Background: Most Epstein-Barr virus (EBV) associated lymphoproliferative disorders have high proliferation indices. However, classical Hodgkin's disease (cHD) is heterogeneous, with respect to proliferation index of the Reed-Sternberg cell (RS cell), and EBV association. Hence, we investigated whether cHD with and without EBV-association differ with respect to the proliferation index of the RS cells. Further we investigated whether this would have a bearing on patients survival.
Introduction
In culture systems, B lymphocytes, on infection by Epstein-Barr virus (EBV) transform into continuously proliferating cells (immortalization) [1] . Most EBVassociated non Hodgkin's lymphomas (NHL), like Burkitt's lymphoma, HIV-associated lymphomas, posttransplant lymphoproliferations, sino-nasal T/NK-cell lymphomas and peripheral T-cell lymphomas are high grade lymphomas and, in general, have a high proliferation index [2] . On the other hand, incidence of EBV-association is extremely low in low-grade B-cell lymphomas and most of them have a low proliferation index. Many recent studies have suggested that Hodgkin's disease (HD) is a B-cell neoplasm. The Reed-Sternberg cells (RS cell) in classical HD (cHD) is thought to be of germinal centre B-cell origin and on many occasions expresses B-cell antigens [3, 4] . However, cHD is heterogeneous, both with respect to the proportion of the putative neoplastic cells -RS cells expressing proliferation associated antigens, and with respect to EBVassociation [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] .
The relationship between EBV-association and proliferation in lymphomas has not been addressed. Since most other EBV associated lymphoproliferations have a high proliferation index, the question whether EBV would help tumour cells to continuously stay in the cell cycle cannot be addressed in them. We thought that this question could be best addressed in cHD where proliferation index in the RS cells is highly variable [7, 16] . Hence, we investigated whether cHD with and without EBV association differ with respect to the proliferation index of the RS cells. Further, we have also probed whether the EBV association has any bearing on patients survival.
Patients and methods

Patients
Lymph node tissues biopsied at presentation, from one hundred and ten patients of cHD during the period January 1984 to December 1988 were selected for the study after excluding cases of nodular lymphocyte predominant HD and unclassified HD. Criteria suggested in the [19, 20] . Staging information by Ann Arbor staging system was available in all patients. The patients had been treated with standard chemotherapy protocols and external radiotherapy. The patients were followed up for 57 ± 39 months. Eleven patients did not achieve complete remission Relapse was noted in 23 patients and 15 patients died due to disease progression.
Immunohistochemical analysis
Four micron thick paraffin sections were immunostained using mouse monoclonal antibodies to EBV latent membrane protein-1 (LMP-1) (CS1-4, Novocastra) and proliferating cell nuclear antigen (PCNA) (PC-10, DAKO, Denmark). The deparaffinised tissue sections [except for PCNA] were treated in a microwave oven for 10 minutes for antigen retrieval. The primary antibodies were used in a dilution of 1 :50 and localised by the Avidin-Biotin-peroxidase technique (Vectastain Elite ABC kits; Vector laboratories). A tissue section of cHD that was known to be positive for LMP-1 served as a positive control. Ten microscopic fields with a 20X objective were assessed for PCNA expression in the RS cells. The PCNA expression was graded by the proportion of RS cells positive for PCNA: I = 25%; II = 26%-50%; III = 51%-75%; IV = 76%-90%; V = >90%. For standardising the PCNA immunostaining, the primary antibody dilution was first titrated by performing immunohistochemistry on a reactive lymph node with follicular hyperplasia. At a dilution of 1: 50, we had optimal results with most follicular centre cells being positive and most mantle cells and interfollicular cells being negative. The same dilution was used through out the analysis. A section of the same lymph node was used as a control slide with every batch of HD cases tested. Internal positive controls (such as remnant germinal centres and other proliferating non-neoplastic lymphoid cells) and internal negative controls were also taken into account during the analysis. LMP-1 was scored as positive if more than 10% RS cells were positive.
In situ hybridisation
Standard precautions to avoid RNase contamination were followed. Deparaffinised slides were subjected to pronase digestion for 10 minutes at 37 °C prior to hybridisation. 25 ul of the diluted (1:10 in standard hybridisation buffer) and denatured digoxigenin labelled anti-sense Epstein-Barr virus encoded nuclear RNA-1 (EBER-1) was applied to each section and hybridisation carried out at 55 °C for two hours. Following post-hybridisation washes, digoxigenin was localised by incubation with alkaline phosphatase labelled anti-digoxigenin antibody for one hour at room temperature and colour developed with nitroblue tetrazolium and X-phosphate. Sections of cHD that were previously identified to be EBER-1 + served as positive controls.
Statistical analysis
Patients were grouped into two age groups: $ 14 years and > 14 years. Proliferation status was defined as: low proliferation -PCNA grades 1 and 2 and high proliferation -PCNA grades 3,4 and 5. Stages I and II were considered low stage and stages III and IV were considered as high stage. Since we had a single case of lymphocyte depleted cHD, the case was added to the nodular sclerosis group while performing statistical correlations. For categoric variables, chi-quadratic test was used. To evaluate the difference in the mean between continuous variables, independent sample (-test was used. For multivariate analysis, step-wise logistic regression model was utilised to determine the correlation of EBV association with age group, sex, stage, histologic subtype, and proliferation. Overall survival (OS) and relapse-free survival (RFS) were correlated with age groups, sex, EBV association, stage, histology and proliferation by log-rank test and Kaplan-Meier analysis. The significance of these characteristics was further tested in Cox proportional hazard model. The SPSS statistical software, version 6.1 for Windows was used for the analysis.
Results
The 110 cases of cHD, included 52 cases of mixed cellularity (47%), 41 cases of nodular sclerosis (37%), 16 cases of lymphocyte rich cHD (14.5%) and 1 case of lymphocyte depleted subtype. Patients'ages ranged from 4-61 years (mean age 22 years) and included 86 males and 24 females. Fifty (45%) patients were in the age group of ^ 14 years and 60 patients (55%) were > 14 years of age. Twenty-five (23%), thirty-one (28%), thirtyeight (35%) and sixteen (15%) patients were in stage I, II, III and IV, respectively. Eighty-six of one hundred ten cases (78%) were positive for EBER-1. The reaction was limited to the nucleus and in the positive cases almost all RS cells were positive. EBER-1 staining was limited to the RS cells, except for occasional positivity in a bystander lymphocyte in some cases. LMP-1 expression was seen in 56 cases (51%) and was restricted to RS cells. LMP-1 expression was seen on the cell surface and in the cytoplasm, as a granular signal. A case was considered EBV-associated if either EBER-1 or LMP-1 was positive. However, all cases positive for LMP-1 showed EBER-1 expression as well.
All the samples were positive for PCNA, but to a varying extent. The expression was not restricted to RS cells or their variants. The background lymphoid cells also showed positive staining. Although the staining was predominantly seen in the nucleus, the cytoplasm also stained lightly in some of the RS cells. The number of RS cells positive for PCNA varied in different cases and were graded as 1 in 9 cases (8%), 2 in 14 cases (13%), 3 in 
Statistical analysis
Univariate analysis. EBV-association correlated with high proliferation (P = 0.002) and age < 14 years (P < 0.001). Twelve of twenty-three cases (52%) with low proliferation in RS cells and seventy-four of eightyseven cases (85%) with high proliferation in RS cells were EBV associated. While only 33% of cases with PCNA grade 1 expression had EBV association, 100% of cases with PCNA grade 5 expression were EBV associated. Forty-nine of fifty patients (98%) in the age group of J% 14 years and thirty-seven of sixty (62%) in patients > 14 years of age were EBER-1 positive. The median ages of patients in EBER-1 positive and negative subgroups were 13 years and 34 years, respectively (P < 0.001).
Multivariate analysis. EBV association correlated independently with age > 14 years, high proliferation and histologic subtype (P -0.001, 0.004 and 0.027, respectively). Proliferation correlated independently only with EBV association (P -0.004, RR 6.4) and with none of the other parameters.
Survival. The 10 year RFS was significantly better in patients in stages I and II as compared to patients in stages III and IV (78% vs. 38%) (P = 0.006), in cases with high proliferation as compared to those with low Relapse free survival (months) Figure 1 . Relapse-free survival in patients with and without EBV association. proliferation (69% vs. 26%) (P -0.04), in cases with EBV-association as compared to those without EBV association (60% vs. 44%, P -0.03) (Figure 1 ). On multivariate analysis, only stage (P -0.008) and EBVassociation (P = 0.03) independently correlated with RFS. The 10-year OS was significantly better in cases with EBV association as compared to those without EBV association (85% vs. 64%, P = 0.03) (Figure 2) . On multivariate analysis, only EBV association (P -0.04) independently correlated with OS.
Discussion
Geographic differences in the association of EBV with HD are well known. While in the developing countries 70%-100% of HD are EBV associated, only 30%-50% of HD in the developed countries show such an association. In the Oriental population from China and Hong Kong, the association is intermediate (65%) [5, 6,10, 2 1 -28] . Within HD, mixed cellularity subtype has a stronger association as compared to the nodular sclerosis subtype [21, 29] . Analogous to these previous observations, in the current study EBV association was noted among 86% of mixed cellularity and 68% of nodular sclerosis subtypes of cHD. The overall EBV association with cHD was 78%, and among children, the association was 98%. Many of the earlier studies have shown an association between EBV positivity and patient's age. The association is reported to be stronger in children and in elderly patients [6, 10, 29] . The stronger association with EBV in these subsets of patients might be related to environmental factors and to the patient's lowered immune status.
In a developing country EBV might be acquired at an earlier age, and this, compounded by the lower socioeconomic status might play a role in altering the immune status of the EBV infected children. Further, EBV-association is significantly higher among Hispanics compared to whites hailing from similar geographic locations [28] . Thus, age, ethnicity and physiologic effects of poverty may function as biologic modifiers that could account for EBV association in HD [5, 6, 22, 30] .
Our study suggests that in situ hybridization (ISH) with EBER-1 is far more sensitive for detection of EBV association in HD than immunohistochemistry (IHC) with anti-LMP-1 antibody. Though some studies suggest that LMP-1 is as sensitive as EBER-1, there are several other studies which suggest EBER-1-ISH is more sensitive [8] [9] [10] [11] [12] [13] . The difference in the EBV detection rate as documented by the two techniques has varied between 12% and 24% in the published studies. In our study EBV-association was documented in 78% cases by EBER-1-ISH and in 50% cases by LMP-1-IHC. Studies that have undertaken a combined ISH and IHC strategy where both techniques were performed on same sections showed that only 69% of EBER-1 positive RS cells expressed LMP-1 [31] .
It has long been debated whether EBV association in HD was merely coincidental or whether EBV had indeed an important role in the pathogenesis of HD [2] . Though the exact role of EBV in the pathogenesis of HD is far from clear, Southern blot analysis has shown that the EBV harboured in samples of HD is monoclonal. The monoclonality of the EBV-DNA implies that the RS cells are infected before malignant transformation [28] .
In our study, EBV association was the strongest and also an independent predictor of 10-year OS, with EBV+ patients having 21% advantage over EBV-patients. Patients with EBV+ cHD also had a better 10-year RFS than patients with EBV-cHD, with a 16% advantage. Furthermore, patients with a high proliferation had a better 10 year RFS with an advantage of 42% over those with low expression. There have been earlier studies addressing the question whether the EBV+ cHD has a different clinical course as compared to EBV-cHD. The study of Morente et al. [32] has reported an improved survival in cases of EBV+ HD. Further, the recent study of Murray et al. [33] has documented a better response to chemotherapy and an improved two-year failure-free survival for patients with EBV+ cHD. In contrast, the studies of Claviez et al. and Fellbaum et al. have not identified any survival difference between EBV positive and negative subgroups [8, 34] .
The RS cells of HD express several proliferation associated proteins like PCNA, Ki-67, cyclin A, cyclin Bl, cyclin D and cdc2 [7, [14] [15] [16] [17] [18] . Mitotic count has also been used to study proliferation in the RS cells [35] . Further, there have been studies that have aimed at correlating the expression of different proliferation markers in RS cells of HD. One such study documented a positive correlation between PCNA positive and Ki-67 positive RS cells of cHD in 76% of the cases [16] . The proportion of RS cells that express PCNA can vary from less than 25% to over 90%, as was noted in our study [7, 16] .
The core issue which we intended to address in this study was whether the presence of EBV within the RS cells had any bearing on the proliferative potential of the RS cell. This question stemmed from the fact that most other EBV-associated lymphomas have a high proliferative potential. In our study, the majority of cases (85%) with high proliferation in RS cells were EBV associated and the association was independent of all other factors including age. Hence, we hypothesise that EBV confers an increased proliferative potential (ability to remain in the cell cycle) to RS cells of cHD.
There is evidence to suggest that RS cells of HD undergo endomitosis. The observation that most RS cells express cdc2 implies that the majority of RS cells are indeed 'proliferating' [17, 18] . However, the ratio of cells in anaphase/telophase to cells expressing cdc2 is far less among RS cells of cHD in comparison to anaplastic large-cell lymphoma cells (a lymphoma with large atypical neoplastic cells). Similarly, the ratio of cells expressing cytoplasmic and nuclear cyclin Bl to cells expressing cdc2 is far less among RS cells of cHD in comparison to anaplastic large-cell lymphoma cells. Additionally, the degree of multinucleation in the RS cells correlates with cdc2 expression. These findings suggest that RS cells after passing through the G2 phase do not successfully complete the mitosis [18] . They however re-enter the cell cycle and pass through Gl, S and G2 phases, i.e., they undergo endomitosis. Few other studies also lend support to the above observations. By image cytometry, a large proportion of RS cells have been shown to be hyperoctoploid cells [15] . Further, on reculturing of sorted mononucleated cells from the HDLM2 cell line, multinucleated cells can be obtained and the latter cells express Ki-67 and incorporate BrdU [36] . Due to the above attributes, mitoses are rare in RS cells of HD with majority of cases showing less than one mitosis per high power field [35] . Due to the phenomenon of endomitosis, the high 'proliferation' in the RS cells does not translate into a high rate of cell duplication.
Hodgkin's disease is broadly classified as classical HD and nodular lymphocyte predominant HD (NLP-HD) [19, 20] . Though the neoplastic cells of the two subsets differ in morphology and immunophenotype, they have some features in common. It includes nuclear multilobation, large nuclear size and expression of proliferation associated antigens in a high proportion of neoplastic cells [7] . Endomitosis in the neoplastic cells may well be the phenomenon shared by both types of HD. We reiterate that in HD, the expression of proliferation associated antigens is only indicative of the presence of neoplastic cells in the cell cycle and is not a measure of cell duplication rate. The RS cells that do not express proliferation associated antigens are likely to be outside the cell cycle (resting stage). This discussion leaves us with some unanswered questions: How often would such resting RS cells be recruited into the cell cycle? How often and why would the RS cells alternate between endomitotic and mitotic cycles?
The better response to chemotherapeutic agents in EBV associated HD is probably due to the fact that a higher proportion of RS cells are in various phases of cell cycle (not resting), thereby making them more susceptible to chemotherapy/radiotherapy related DNA damage and cell death.
